SCHEMBL3163340

SCHEMBL3163340

CC(=O)NCCNc1cc(NCCNC(=O)/C=C/c2ccc(C(C)C)cc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 4/20 0.51
LMNA P02545 3/20 0.51
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CYP1A2 P05177 2/20 0.43
MAPT P10636 2/20 0.43
ALOX12 P18054 1/20 0.43
NLRP3 Q96P20 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PYGL P06737 1/20 0.41
HDAC2 Q92769 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PIM2 Q9P1W9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163351 1.00 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1LMNAPKMHTT
SCHEMBL3170960 0.91 LMNA (0.53) SMN1; SMN2ALDH1A1LMNAPKMHTT
SCHEMBL3170956 0.91 LMNA (0.53) SMN1; SMN2ALDH1A1LMNAPKMHTT
SCHEMBL3170642 0.89 KMT2A (0.49) SMN1; SMN2ALDH1A1LMNANPC1RAB9A
SCHEMBL3170630 0.89 KMT2A (0.49) SMN1; SMN2ALDH1A1LMNANPC1RAB9A
SCHEMBL3161992 0.88 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1LMNAPKMHTT
SCHEMBL3161981 0.88 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1LMNAPKMHTT
SCHEMBL3168246 0.84 ADORA3 (0.40) SMN1; SMN2CYP1A2MAPTNLRP3ADORA3
SCHEMBL3168238 0.84 ADORA3 (0.40) SMN1; SMN2CYP1A2MAPTNLRP3ADORA3
SCHEMBL3163636 0.83 PIM2 (0.44) ALDH1A1LMNACYP1A2MAPTNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed